The company has received final approval from the United States Food and Drug Administration (USFDA) to market Butalbital, Acetaminophen and Caffeine tablets in strengths of 50mg/325mg/40 mg, Zydus Cadila said in a statement. The drug will be manufactured at Nesher Pharma's manufacturing facility at St. Louis in the US, it added.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/32IzTWz
via IFTTT
0 comments:
Post a Comment